Vectra Felis


pyriproxyfen / dinotefuran

This medicine is authorised for use in the European Union.


This is a summary of the European Public Assessment Report. Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 18/02/2019

Authorisation details

Product details
Vectra Felis
Agency product number
Active substance
  • pyriproxyfen
  • dinotefuran
International non-proprietary name (INN) or common name
pyriproxyfen / dinotefuran
Anatomical therapeutic chemical veterinary (ATCvet) codes
Publication details
Marketing-authorisation holder
Ceva Sante Animale
Date of issue of marketing authorisation valid throughout the European Union
Contact address
La Ballastiere
B.P. 126
33501 Libourne

Product information

08/02/2019 Vectra Felis - EMEA/V/C/002746 - R/0008


Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Antiparasitic products
  • insecticides and repellents
  • Other ectoparasiticides for topical use
  • pyriproxyfen
  • combinations

Therapeutic indication

Treatment and prevention of flea infestation.

Kills adult fleas, flea eggs, larvae and pupae.

One application prevents flea infestation for one month and prevents further flea multiplication by inhibiting flea emergence in the environment of the cat for more than 3 months.

Once applied, dead fleas start falling from the treated animal within 5 min.

The product can be used as part of a treatment strategy on cats for the control of Flea Allergy
Dermatitis (FAD).

Assessment history

How useful was this page?

Add your rating